Esther Landesman

Instructor, Medicine

(617) 638-7022
650 Albany St Evans Biomed Research Ctr

Education

  • Boston University, PhD
  • The Hebrew University of Jerusalem, MS
  • The Hebrew University of Jerusalem, BS

Publications

  • Published on 10/6/2016

    Lian H, Li D, Zhou Y, Landesman-Bollag E, Zhang G, Anderson NM, Tang KC, Roderick JE, Kelliher MA, Seldin DC, Fu H, Feng H. CK2 inhibitor CX-4945 destabilizes NOTCH1 and synergizes with JQ1 against human T-acute lymphoblastic leukemic cells. Haematologica. 2017 Jan; 102(1):e17-e21. PMID: 27758824.

    Read at: PubMed
  • Published on 8/29/2016

    Novikov O, Wang Z, Stanford EA, Parks AJ, Ramirez-Cardenas A, Landesman E, Laklouk I, Sarita-Reyes C, Gusenleitner D, Li A, Monti S, Manteiga S, Lee K, Sherr DH. An Aryl Hydrocarbon Receptor-Mediated Amplification Loop That Enforces Cell Migration in ER-/PR-/Her2- Human Breast Cancer Cells. Mol Pharmacol. 2016 Nov; 90(5):674-688. PMID: 27573671.

    Read at: PubMed
  • Published on 3/16/2016

    Stanford EA, Wang Z, Novikov O, Mulas F, Landesman-Bollag E, Monti S, Smith BW, Seldin DC, Murphy GJ, Sherr DH. The role of the aryl hydrocarbon receptor in the development of cells with the molecular and functional characteristics of cancer stem-like cells. BMC Biol. 2016 Mar 16; 14:20. PMID: 26984638.

    Read at: PubMed
  • Published on 10/10/2012

    Romagnoli M, Belguise K, Yu Z, Wang X, Landesman-Bollag E, Seldin DC, Chalbos D, Barillé-Nion S, Jézéquel P, Seldin ML, Sonenshein GE. Epithelial-to-mesenchymal transition induced by TGF-ß1 is mediated by Blimp-1-dependent repression of BMP-5. Cancer Res. 2012 Dec 1; 72(23):6268-78. PMID: 23054396.

    Read at: PubMed
  • Published on 7/19/2011

    Landesman-Bollag E, Belkina A, Hovey B, Connors E, Cox C, Seldin DC. Developmental and growth defects in mice with combined deficiency of CK2 catalytic genes. Mol Cell Biochem. 2011 Oct; 356(1-2):227-31. PMID: 21769451.

    Read at: PubMed
  • Published on 7/2/2008

    Seldin DC, Lou DY, Toselli P, Landesman-Bollag E, Dominguez I. Gene targeting of CK2 catalytic subunits. Mol Cell Biochem. 2008 Sep; 316(1-2):141-7. PMID: 18594950.

    Read at: PubMed
  • Published on 10/22/2007

    Lou DY, Dominguez I, Toselli P, Landesman-Bollag E, O'Brien C, Seldin DC. The alpha catalytic subunit of protein kinase CK2 is required for mouse embryonic development. Mol Cell Biol. 2008 Jan; 28(1):131-9. PMID: 17954558.

    Read at: PubMed
  • Published on 12/15/2005

    Eddy SF, Guo S, Demicco EG, Romieu-Mourez R, Landesman-Bollag E, Seldin DC, Sonenshein GE. Inducible IkappaB kinase/IkappaB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-kappaB activation in breast cancer cells. Cancer Res. 2005 Dec 15; 65(24):11375-83. PMID: 16357145.

    Read at: PubMed
  • Published on 11/1/2005

    Demicco EG, Kavanagh KT, Romieu-Mourez R, Wang X, Shin SR, Landesman-Bollag E, Seldin DC, Sonenshein GE. RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland. Mol Cell Biol. 2005 Nov; 25(22):10136-47. PMID: 16260626.

    Read at: PubMed
  • Published on 7/1/2005

    Farago M, Dominguez I, Landesman-Bollag E, Xu X, Rosner A, Cardiff RD, Seldin DC. Kinase-inactive glycogen synthase kinase 3beta promotes Wnt signaling and mammary tumorigenesis. Cancer Res. 2005 Jul 1; 65(13):5792-801. PMID: 15994955.

    Read at: PubMed

View 12 more publications: View full profile at BUMC

View all profiles